Recall of Philips imaging devices ‘most serious’: USFDA says
HQ Team December 21, 2023: The US drug regulator has termed its Class I recall of Philips magnetic resonance systems as the “most.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team December 21, 2023: The US drug regulator has termed its Class I recall of Philips magnetic resonance systems as the “most.
HQ Team December 20, 2023: Researchers from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington’s School of Medicine.
HQ Team December 20, 2023: Patients who brush their teeth may be saving themselves from hospital-acquired pneumonia and other outcomes, according to a.
HQ Team December 19, 2023: An increase in Covid-19 cases across the world is causing concern. The surge is attributed to the detection.
HQ Team, December 18, 2023: For individuals grappling with schizophrenia, the road to treatment is often marked by a lifelong commitment to antipsychotic.
HQ Team December 15, 2023: Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in.
HQ Team December 15, 2023: Merck announced it got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form.
HQ Team December 15, 2023: A new vaccine to aid the human body’s white cells to fight HIV infection may hold the key.
HQ Team December 13, 2023: Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of.
HQ Team December 13, 2023: Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com